Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2019.
The company has reported net profit of Rs 468.76 crore for the quarter under review as compared to net loss of Rs 38.68 crore for the same quarter in the previous year. Total income of the company increased by 32.32% at Rs 3,028.91 crore for Q3FY20 as compared Rs 2,289.02 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 26.44% in its net profit after taxes, share of profit of associates and joint ventures and non-controlling interests at Rs 913.52 crore for the quarter under review as compared to Rs 1,241.85 crore for the same quarter in the previous year. However, total income of the company increased by 4.30% at Rs 8,274.73 crore for Q3FY20 as compared Rs 7,933.25 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |